Bill Berkrot
-
Experimental Drug Shows Promise in Reducing Heart Damage
A single dose of an experimental Roche biotech drug that blocks inflammation reduced damage to the heart during artery clearing angioplasty procedures, according to data from a midstage trial presented on Sunday. The drug, inclacumab, was significantly better than a placebo in decreasing levels of molecular markers, or enzymes, that are used to diagnose heart …
Experimental Drug Shows Promise in Reducing Heart Damage Read More »
Recent Posts
- Atheists Rage Over Gigantic Ten Commandments Display
- Deadly Tornadoes Sweep Across the Midwest: ‘Pray for Us’
- 9-Year-Old Hero Sprints More Than a Mile Through Deadly Tornado to Save Parents
- Morning Rundown: Benny Hinn Speaks Out Amid Controversy
- Benny Hinn: ‘I’m a Human Being. I’ve Made Mistakes’